142 related articles for article (PubMed ID: 11736917)
21. Acute generalized exanthematous pustulosis associated with oral terbinafine.
Hall AP; Tate B
Australas J Dermatol; 2000 Feb; 41(1):42-5. PubMed ID: 10715900
[TBL] [Abstract][Full Text] [Related]
22. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
[TBL] [Abstract][Full Text] [Related]
23. Treatment of onychomycosis with terbinafine in patients with Down's syndrome.
Velthuis PJ; Nijenhuis M
Br J Dermatol; 1995 Jul; 133(1):144-6. PubMed ID: 7669630
[No Abstract] [Full Text] [Related]
24. Oral terbinafine treatment for toenail onychomycosis: follow-up after 5-6 years.
Molin L; Tarstedt M; Engman C
Br J Dermatol; 2000 Sep; 143(3):682-3. PubMed ID: 10971374
[No Abstract] [Full Text] [Related]
25. Long-term follow-up of toe-nail onychomycosis treated with terbinafine.
Brandrup F; Larsen PO
Acta Derm Venereol; 1997 May; 77(3):238. PubMed ID: 9188883
[No Abstract] [Full Text] [Related]
26. [Treatment of onychomycosis].
Suhonen R; Karvonen J
Duodecim; 1998; 22(114):2343-50. PubMed ID: 11757097
[No Abstract] [Full Text] [Related]
27. Treatment of onychomycosis with terbinafine.
Baudraz-Rosselet F; Rakosi T; Wili PB; Kenzelmann R
Br J Dermatol; 1992 Feb; 126 Suppl 39():40-6. PubMed ID: 1531928
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J
Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743
[TBL] [Abstract][Full Text] [Related]
29. [On fungus and taste].
Backhaus E
Lakartidningen; 2012 Dec 19-2013 Jan 8; 109(51-52):2368. PubMed ID: 23367556
[No Abstract] [Full Text] [Related]
30. Onychomycosis. New therapies for an old disease.
Gupta AK; Scher RK; De Doncker P; Sauder DN; Shear NH
West J Med; 1996 Dec; 165(6):349-51. PubMed ID: 9000854
[TBL] [Abstract][Full Text] [Related]
31. Hypersensitivity syndrome reaction to oral terbinafine.
Gupta AK; Porges AJ
Australas J Dermatol; 1998 Aug; 39(3):171-2. PubMed ID: 9737044
[TBL] [Abstract][Full Text] [Related]
32. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
Bräutigam M; Nolting S; Schopf RE; Weidinger G
BMJ; 1995 Oct; 311(7010):919-22. PubMed ID: 7580551
[TBL] [Abstract][Full Text] [Related]
33. Terbinafine and onychomycosis.
Eastcott DF
N Z Med J; 1991 Jan; 104(904):17. PubMed ID: 1826145
[No Abstract] [Full Text] [Related]
34. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.
Elewski B; Pollak R; Ashton S; Rich P; Schlessinger J; Tavakkol A
Br J Dermatol; 2012 Feb; 166(2):389-98. PubMed ID: 21967490
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
Tavakkol A; Fellman S; Kianifard F
Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
[TBL] [Abstract][Full Text] [Related]
36. Single dose treatment of fungal nail disease.
Shuster S; Munro CS
Lancet; 1992 Apr; 339(8800):1066. PubMed ID: 1349100
[No Abstract] [Full Text] [Related]
37. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
[TBL] [Abstract][Full Text] [Related]
38. A randomized treatment duration-finding study of terbinafine in onychomycosis.
van der Schroeff JG; Cirkel PK; Crijns MB; Van Dijk TJ; Govaert FJ; Groeneweg DA; Tazelaar DJ; De Wit RF; Wuite J
Br J Dermatol; 1992 Feb; 126 Suppl 39():36-9. PubMed ID: 1531927
[TBL] [Abstract][Full Text] [Related]
39. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
Paredes AH; Lewis JH
Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
[TBL] [Abstract][Full Text] [Related]
40. Isolated thrombocytopenia associated with oral terbinafine.
Tsai HH; Lee WR; Hu CH
Br J Dermatol; 2002 Sep; 147(3):627-8. PubMed ID: 12207625
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
